Status:
WITHDRAWN
Association Between Cancer Cells and Normal Versus (Vs.) Low Levels of Thyroid Hormones in the Serum
Lead Sponsor:
Meir Medical Center
Conditions:
Thyroid Cancer
Eligibility:
All Genders
20-80 years
Brief Summary
Much experimental data has suggested that thyroid hormones (T3 and T4) may modulate neoplastic cells and that T3/T4 deprivation may remove this stimulus. It is now well established that T3/T4 affects ...
Eligibility Criteria
Inclusion
- Hypothyroid state
Exclusion
- Non hypothyroid state
Key Trial Info
Start Date :
February 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01153945
Start Date
February 1 2011
End Date
July 1 2011
Last Update
April 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir Medical Center
Kfar Saba, Israel